Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Pigment Cell & Melanoma Research|April 12, 2011
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibitionKarine A Cohen-Solal, Kim T Merrigan, Joseph L-K Chan, et al.
Small Methods|October 25, 2024
Scalable Copper Sulfide Formulations for Super-Resolution Optoacoustic Brain Imaging in the Second Near-Infrared WindowLin Tang, Daniil Nozdriukhin, Sandeep Kumar Kalva, et al.
Plos One|March 13, 2014
Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinomaJohn C Morris, Antoinette R Tan, Thomas E Olencki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivoRongrong Ge, Vaishali Rajeev, Partha Ray, et al.
Molecular Cancer|May 28, 2010
Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasisVidya Ganapathy, Rongrong Ge, Alison Grazioli, et al.
Biochemical Pharmacology|June 9, 2004
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signalingRongrong Ge, Vaishali Rajeev, Gayathri Subramanian, et al.
Pharmacology & Therapeutics|May 17, 2012
Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imagingMarlous Arjaans, Thijs H Oude Munnink, Hetty Timmer-Bosscha, et al.
The Breast Journal|November 18, 2003
Sequential high-dose alkylating therapy and stem cell support for high-risk stage III breast cancerJosette Bou-Khalil, Michal Rose, Amanda Psyrri, et al.
Breast Cancer Research and Treatment|October 20, 2006
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancerMaysa M Abu-Khalaf, Vinni Juneja, Gina G Chung, et al.
The Journal of Biological Chemistry|January 21, 2004
Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginoneSandhya Xavier, Ester Piek, Makiko Fujii, et al.
Pageof 10